UNQ HOLDINGS (02177) Plans to Acquire Japanese Consultative Pharmacy Chain Akahige Pharmacy for ¥2.701 Billion

Stock News
2025/12/15

UNQ HOLDINGS (02177) announced that on December 15, 2025, its wholly-owned subsidiary, UNQ Japan Co., Ltd., intends to acquire a 90% stake in One Two Co., Ltd. for a total consideration of ¥2.701 billion. Upon completion, the target company will be indirectly held by UNQ HOLDINGS with approximately 90% ownership, making it an indirect non-wholly-owned subsidiary.

The target company is a limited liability company incorporated in Japan and operates Akahige Pharmacy, a leading consultative pharmacy chain specializing in sexual health and wellness. With over 33 years of market presence in Japan, Akahige Pharmacy operates more than nine locations across Hokkaido, Honshu, and Kyushu. Its core business focuses on providing personalized solutions for middle-aged and elderly men, addressing key sexual health concerns such as erectile dysfunction, premature ejaculation, and male menopause.

Beyond over-the-counter medications, Akahige Pharmacy has developed several patented sexual wellness products, including "Vigor King" and "Power Missile," aimed at supporting men's health and vitality.

UNQ HOLDINGS believes the acquisition will strengthen its foothold in Japan's pharmacy sector by leveraging Akahige Pharmacy's nationwide retail network. Additionally, the group expects synergies from the target company's established relationships with Japanese suppliers and logistics networks, aligning with its broader business strategy.

Post-acquisition, UNQ HOLDINGS plans to reassess and optimize the target company's financial position, potentially divesting non-core assets and reinvesting proceeds into new patented product development and brand expansion.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10